Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
About
Physical chemist and pioneer in live cell printing technology. He serves as executive director of the Innovative Genomics Institute at UC Berkeley and previously directed the Biological Technologies Office at DARPA, managing research programs in genome editing, neurotechnology, biomanufacturing, and diagnostics.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas C Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
Gregg L. Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John P. Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital
Joni Mancini
Managing Partner at Medical Excellence Capital